The effect of anti-L-selectin (aselizumab) in multiple traumatized patients--results of a phase II clinical trial.
Seekamp A, van Griensven M, Dhondt E, Diefenbeck M, Demeyer I, Vundelinckx G, Haas N, Schaechinger U, Wolowicka L, Rammelt S, Stroobants J, Marzi I, Brambrink AM, Dziurdzik P, Gasiorowski J, Redl H, Beckert M, Khan-Boluki J.
Seekamp A, et al. Among authors: vundelinckx g.
Crit Care Med. 2004 Oct;32(10):2021-8. doi: 10.1097/01.ccm.0000142396.59236.f3.
Crit Care Med. 2004.
PMID: 15483410
Clinical Trial.